All donations up to $200,000 matched before June 30 Donate

Immune to Cancer: The CRI Blog

Let's spread the word about Immunotherapy! Click to share this page with your community.
Copy Link

Kymriah, a CAR T cell immunotherapy, approved for lymphoma

May 3, 2018Arthur N. Brodsky, Ph.D.
A second CAR T cell immunotherapy targeting the CD19 receptor was approved by the FDA for patients with relapsed or refractory large B cell lymphoma.

Read More

Filter by:

*Immunotherapy results may vary from patient to patient.